Infectious Disease Rapid Diagnostic Testing Market Updates by 2031
The infectious disease rapid diagnostic testing kits are used for diagnosis of different infectious disease in relatively less time. Infectious diseases are the disorders transmitted by organisms such as bacteria, virus, fungi which leads to an infection. These diseases can also be transmitted from person to person. Various methods are available for rapid testing of infectious disease such as assay methods as well as with help of instruments. Various infectious disease such as, hepatitis, TB, HPV need to be diagnose early for best treatment options.
MARKET DYNAMICS
The key market drivers for Infectious Disease Rapid Diagnostic Testing Kits Market Includes, rising incidences of infectious disease across the globe. Additionally, shift of centralized laboratories to decentralized laboratories is also a major driving factor for the market. Moreover, technological advancements in diagnosis of infectious diseases along with increasing R&D findings are expected to fuel market growth during the forecast period. However, Poor reimbursement policies in developing countries as well as lack of skilled personnel to perform test is expected to have a negative effect on market growth during the forecast period.
MARKET SCOPE
The "Infectious Disease Rapid Diagnostic Testing Kits Market" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Infectious Disease Rapid Diagnostic Testing Kits market with detailed market segmentation by product, disease type, technology and end user. The Infectious Disease Rapid Diagnostic Testing Kits Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Infectious Disease Rapid Diagnostic Testing Kits Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Infectious Disease Rapid Diagnostic Testing Kits Market is segmented on the basis of product, disease type, technology and end user. On the basis of product the market is segmented as, assay and instruments. On basis of disease type the market is divided into, hepatitis, HIV, TB, HPV, and Influenza. On the basis of technology the market is segmented as, immunodiagnostics, clinical microbiology, PCR, INAAT and others. And on the basis of end user the market is segmented as, hospitals, clinics, diagnostic laboratories and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Infectious Disease Rapid Diagnostic Testing Kits Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Infectious Disease Rapid Diagnostic Testing Kits Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Infectious Disease Rapid Diagnostic Testing Kits Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Infectious Disease Rapid Diagnostic Testing Kits Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Infectious Disease Rapid Diagnostic Testing Kits Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Infectious Disease Rapid Diagnostic Testing Kits Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Infectious Disease Rapid Diagnostic Testing Kits Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Infectious Disease Rapid Diagnostic Testing Kits Market in these regions.
MARKET PLAYERS
The report covers key developments in the Infectious Disease Rapid Diagnostic Testing Kits Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Infectious Disease Rapid Diagnostic Testing Kits Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Infectious Disease Rapid Diagnostic Testing Kits market in the global market. Below mentioned is the list of few companies engaged in the Infectious Disease Rapid Diagnostic Testing Kits Market.
The report also includes the profiles of key players in Infectious Disease Rapid Diagnostic Testing Kits Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Becton Dickinson and Company
- Biomerieux SA
- Danaher Corporation
- Siemens AG
- Bio-Rad Laboratories
- Diasorin
- Luminex
- Meridian Bioscience
- Roche Diagnostics
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Infectious Disease Rapid Diagnostic Testing Market - By Product
1.3.2 Infectious Disease Rapid Diagnostic Testing Market - By Disease Type
1.3.3 Infectious Disease Rapid Diagnostic Testing Market - By Technology
1.3.4 Infectious Disease Rapid Diagnostic Testing Market - By End User
1.3.5 Infectious Disease Rapid Diagnostic Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING - GLOBAL MARKET OVERVIEW
6.2. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ASSAY
7.3.1. Overview
7.3.2. Assay Market Forecast and Analysis
7.4. INSTRUMENTS
7.4.1. Overview
7.4.2. Instruments Market Forecast and Analysis
8. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
8.1. OVERVIEW
8.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
8.3. HEPATITIS
8.3.1. Overview
8.3.2. Hepatitis Market Forecast and Analysis
8.4. HIV
8.4.1. Overview
8.4.2. HIV Market Forecast and Analysis
8.5. HAIS
8.5.1. Overview
8.5.2. HAIs Market Forecast and Analysis
8.6. HPV
8.6.1. Overview
8.6.2. HPV Market Forecast and Analysis
8.7. TB
8.7.1. Overview
8.7.2. TB Market Forecast and Analysis
8.8. INFLUENZA
8.8.1. Overview
8.8.2. Influenza Market Forecast and Analysis
8.9. OTHER DISEASES
8.9.1. Overview
8.9.2. Other Diseases Market Forecast and Analysis
9. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. IMMUNODIAGNOSTICS
9.3.1. Overview
9.3.2. Immunodiagnostics Market Forecast and Analysis
9.4. CLINICAL MICROBIOLOGY
9.4.1. Overview
9.4.2. Clinical Microbiology Market Forecast and Analysis
9.5. PCR
9.5.1. Overview
9.5.2. PCR Market Forecast and Analysis
9.6. INAAT
9.6.1. Overview
9.6.2. INAAT Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS
10.3.1. Overview
10.3.2. Hospitals Market Forecast and Analysis
10.4. CLINICS
10.4.1. Overview
10.4.2. Clinics Market Forecast and Analysis
10.5. DIAGNOSTIC LABORATORIES
10.5.1. Overview
10.5.2. Diagnostic Laboratories Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. Others Market Forecast and Analysis
11. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Infectious Disease Rapid Diagnostic Testing Market Overview
11.1.2 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.1.3 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.1.4 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.1.5 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.1.6 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.1.7 North America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Infectious Disease Rapid Diagnostic Testing Market
11.1.7.1.1 United States Infectious Disease Rapid Diagnostic Testing Market by Product
11.1.7.1.2 United States Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.1.7.1.3 United States Infectious Disease Rapid Diagnostic Testing Market by Technology
11.1.7.1.4 United States Infectious Disease Rapid Diagnostic Testing Market by End User
11.1.7.2 Canada Infectious Disease Rapid Diagnostic Testing Market
11.1.7.2.1 Canada Infectious Disease Rapid Diagnostic Testing Market by Product
11.1.7.2.2 Canada Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.1.7.2.3 Canada Infectious Disease Rapid Diagnostic Testing Market by Technology
11.1.7.2.4 Canada Infectious Disease Rapid Diagnostic Testing Market by End User
11.1.7.3 Mexico Infectious Disease Rapid Diagnostic Testing Market
11.1.7.3.1 Mexico Infectious Disease Rapid Diagnostic Testing Market by Product
11.1.7.3.2 Mexico Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.1.7.3.3 Mexico Infectious Disease Rapid Diagnostic Testing Market by Technology
11.1.7.3.4 Mexico Infectious Disease Rapid Diagnostic Testing Market by End User
11.2. EUROPE
11.2.1 Europe Infectious Disease Rapid Diagnostic Testing Market Overview
11.2.2 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.2.3 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.2.4 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.2.5 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.2.6 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.2.7 Europe Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Infectious Disease Rapid Diagnostic Testing Market
11.2.7.1.1 Germany Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.1.2 Germany Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.1.3 Germany Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.1.4 Germany Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.2 France Infectious Disease Rapid Diagnostic Testing Market
11.2.7.2.1 France Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.2.2 France Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.2.3 France Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.2.4 France Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.3 Italy Infectious Disease Rapid Diagnostic Testing Market
11.2.7.3.1 Italy Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.3.2 Italy Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.3.3 Italy Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.3.4 Italy Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.4 Spain Infectious Disease Rapid Diagnostic Testing Market
11.2.7.4.1 Spain Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.4.2 Spain Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.4.3 Spain Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.4.4 Spain Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.5 United Kingdom Infectious Disease Rapid Diagnostic Testing Market
11.2.7.5.1 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.5.2 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.5.3 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.5.4 United Kingdom Infectious Disease Rapid Diagnostic Testing Market by End User
11.2.7.6 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market
11.2.7.6.1 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by Product
11.2.7.6.2 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.2.7.6.3 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by Technology
11.2.7.6.4 Rest of Europe Infectious Disease Rapid Diagnostic Testing Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Overview
11.3.2 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.3.5 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.3.6 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Infectious Disease Rapid Diagnostic Testing Market
11.3.7.1.1 Australia Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.1.2 Australia Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.1.3 Australia Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.1.4 Australia Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.2 China Infectious Disease Rapid Diagnostic Testing Market
11.3.7.2.1 China Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.2.2 China Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.2.3 China Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.2.4 China Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.3 India Infectious Disease Rapid Diagnostic Testing Market
11.3.7.3.1 India Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.3.2 India Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.3.3 India Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.3.4 India Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.4 Japan Infectious Disease Rapid Diagnostic Testing Market
11.3.7.4.1 Japan Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.4.2 Japan Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.4.3 Japan Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.4.4 Japan Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.5 South Korea Infectious Disease Rapid Diagnostic Testing Market
11.3.7.5.1 South Korea Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.5.2 South Korea Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.5.3 South Korea Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.5.4 South Korea Infectious Disease Rapid Diagnostic Testing Market by End User
11.3.7.6 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market
11.3.7.6.1 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by Product
11.3.7.6.2 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.3.7.6.3 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by Technology
11.3.7.6.4 Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Overview
11.4.2 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.4.5 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.4.6 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Infectious Disease Rapid Diagnostic Testing Market
11.4.7.1.1 South Africa Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.1.2 South Africa Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.1.3 South Africa Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.1.4 South Africa Infectious Disease Rapid Diagnostic Testing Market by End User
11.4.7.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market
11.4.7.2.1 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.2.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.2.3 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.2.4 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market by End User
11.4.7.3 U.A.E Infectious Disease Rapid Diagnostic Testing Market
11.4.7.3.1 U.A.E Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.3.2 U.A.E Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.3.3 U.A.E Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.3.4 U.A.E Infectious Disease Rapid Diagnostic Testing Market by End User
11.4.7.4 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market
11.4.7.4.1 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by Product
11.4.7.4.2 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.4.7.4.3 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by Technology
11.4.7.4.4 Rest of Middle East and Africa Infectious Disease Rapid Diagnostic Testing Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Infectious Disease Rapid Diagnostic Testing Market Overview
11.5.2 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis
11.5.3 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Product
11.5.4 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Disease Type
11.5.5 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Technology
11.5.6 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By End User
11.5.7 South and Central America Infectious Disease Rapid Diagnostic Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Infectious Disease Rapid Diagnostic Testing Market
11.5.7.1.1 Brazil Infectious Disease Rapid Diagnostic Testing Market by Product
11.5.7.1.2 Brazil Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.5.7.1.3 Brazil Infectious Disease Rapid Diagnostic Testing Market by Technology
11.5.7.1.4 Brazil Infectious Disease Rapid Diagnostic Testing Market by End User
11.5.7.2 Argentina Infectious Disease Rapid Diagnostic Testing Market
11.5.7.2.1 Argentina Infectious Disease Rapid Diagnostic Testing Market by Product
11.5.7.2.2 Argentina Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.5.7.2.3 Argentina Infectious Disease Rapid Diagnostic Testing Market by Technology
11.5.7.2.4 Argentina Infectious Disease Rapid Diagnostic Testing Market by End User
11.5.7.3 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market
11.5.7.3.1 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by Product
11.5.7.3.2 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by Disease Type
11.5.7.3.3 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by Technology
11.5.7.3.4 Rest of South and Central America Infectious Disease Rapid Diagnostic Testing Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BECTON DICKINSON AND COMPANY
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOMéRIEUX SA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. DANAHER CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. BIO-RAD LABORATORIES
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SIEMENS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. DIASORIN
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. LUMINEX
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. MERIDIAN BIOSCIENCE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ROCHE DIAGNOSTICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Abbott Laboratories
2. Becton Dickinson and Company
3. Biomérieux SA
4. Danaher Corporation
5. Bio-Rad Laboratories
6. Siemens AG
7. Diasorin
8. Luminex
9. Meridian Bioscience
10. Roche Diagnostics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For